Like_老虎社区_美港股上老虎

ALi_BaBa
2021-12-13

3 Reasons CVS Health Is a Top Dividend Stock to Buy Now

Adding this unique healthcare conglomerate to your portfolio now could lead to heaps of dividend income down the road.

3 Reasons CVS Health Is a Top Dividend Stock to Buy Now

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":604208881,"tweetId":"604208881","gmtCreate":1639397221097,"gmtModify":1639397221387,"author":{"id":3564105303063302,"idStr":"3564105303063302","authorId":3564105303063302,"authorIdStr":"3564105303063302","name":"ALi_BaBa","avatar":"https://static.tigerbbs.com/d89722c800111c9c885624fce940701f","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":7,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":18,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Like&nbsp;</p></body></html>","htmlText":"<html><head></head><body><p>Like&nbsp;</p></body></html>","text":"Like","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/604208881","repostId":2191144607,"repostType":4,"repost":{"id":"2191144607","kind":"highlight","pubTimestamp":1639396223,"share":"https://www.laohu8.com/m/news/2191144607?lang=&edition=full","pubTime":"2021-12-13 19:50","market":"us","language":"en","title":"3 Reasons CVS Health Is a Top Dividend Stock to Buy Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2191144607","media":"Motley Fool","summary":"Adding this unique healthcare conglomerate to your portfolio now could lead to heaps of dividend income down the road.","content":"<p>Promises made, promises kept. That was <a href=\"https://laohu8.com/S/AONE.U\">one</a> big theme in this year's investor day presentation from <b>CVS Health</b> (NYSE:CVS). Recently, the healthcare giant laid out its plans for the years ahead, and the expectations aren't entirely unreasonable.</p>\n<p>If you've been thinking about adding this dividend-paying stock to your portfolio, now looks like a great time to act for a lot of good reasons. Here are three of the most important ones.</p>\n<h2>1. Dividend raises ahead</h2>\n<p>CVS Health is generally a reliable dividend raiser, but the company froze its payout in place in 2017 to help with the $69 billion acquisition of Aetna in 2018. CVS Health took on a lot of debt to become a healthcare benefits manager and wisely decided to freeze dividend payments in place until its financial leverage ratio reached a more comfortable level.</p>\n<p><img src=\"https://static.tigerbbs.com/ea28b7c44acab1d1bd044a5b4673b282\" tg-width=\"720\" tg-height=\"449\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>CVS Dividend data by YCharts</p>\n<p>The company's a bit more levered up than it was just ahead of the Aetna acquisition. At a financial leverage ratio below 0.8, though, it's more than likely safe to show shareholders a lot more appreciation.</p>\n<p>Effective Feb. 1, 2022, patient CVS Health shareholders will receive a $0.55 dividend payment or 10% more than they've been receiving since late 2017. Also, the company intends to return $10 billion to investors in the form of share buybacks.</p>\n<p>At recent prices, the impending buybacks could reduce CVS Health's outstanding share count by more than 7% at recent prices. This will make it even easier to bump the payout higher in the years ahead.</p>\n<h2>2. Chance to outdo UnitedHealth</h2>\n<p>Thanks to the Affordable Care Act, private healthcare plan sponsors, Medicare, and Medicaid increasingly pay fixed rates for specific conditions. This means running patients through more tests and services than they need leads to losses on the bottom line for companies like CVS Health. It also means that coordinating primary care in a way that keeps patients healthy and out of the hospital can lead to windfall profits.</p>\n<p><b>UnitedHealth Group</b> (NYSE:UNH) doesn't bring in quite as much revenue as CVS Health, but it's been generating around twice as much net income. A large part of UnitedHealth's rise to the top can be attributed to an internal network of doctors. UnitedHealth employs or at least has a relationship with 60,000 U.S. physicians. Taking money from healthcare plan sponsors and using it to pay providers is a lot easier to manage when you employ the providers.</p>\n<p><img src=\"https://static.tigerbbs.com/5ac3d5c608e51025677678036d4486d5\" tg-width=\"720\" tg-height=\"497\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>CVS Revenue (TTM) data by YCharts</p>\n<p>CVS Health employs more pharmacists than UnitedHealth, but drugs are a relatively minor expense. In 2019, National Health Expenditure data found that prescription drugs made up just 10% of America's $3.8 trillion healthcare bill that year. Physician and clinical services worked out to 21% and hospitals soaked up the largest share at 30% of total healthcare spending.</p>\n<p>With more than 9,000 physical locations spread throughout the U.S., CVS Health has a chance to employ more of the cost-saving measures that UnitedHealth Group enjoys. At the moment, CVS Health manages 1,200 walk-in medical clinics that employ around 4,000 nurse practitioners and physician assistants. It won't happen overnight, but better coordination of primary care could make CVS Health's profit margins resemble United Health's.</p>\n<h2>3. Ability to keep raising the payout</h2>\n<p>At recent prices, CVS Health stock offers a 2.2% yield and a pretty good chance to see that payout rise into the clouds. Over the past year, CVS Health generated a whopping $15.2 billion in free cash flow and used just $2.7 billion to make payments.</p>\n<p>With its debt load under control, the company can raise its dividend payout in line with earnings growth. Vaccine distribution revenue might slacken in the years ahead but growth ahead seems like a reasonable prediction. A steadily aging U.S. population is going to need more healthcare year after year for decades to come.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Reasons CVS Health Is a Top Dividend Stock to Buy Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Reasons CVS Health Is a Top Dividend Stock to Buy Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-13 19:50 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/13/3-reasons-cvs-health-is-top-dividend-stock-to-buy/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Promises made, promises kept. That was one big theme in this year's investor day presentation from CVS Health (NYSE:CVS). Recently, the healthcare giant laid out its plans for the years ahead, and the...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/13/3-reasons-cvs-health-is-top-dividend-stock-to-buy/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4196":"保健护理服务","BK4504":"桥水持仓","BK4550":"红杉资本持仓","CVS":"西维斯健康"},"source_url":"https://www.fool.com/investing/2021/12/13/3-reasons-cvs-health-is-top-dividend-stock-to-buy/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2191144607","content_text":"Promises made, promises kept. That was one big theme in this year's investor day presentation from CVS Health (NYSE:CVS). Recently, the healthcare giant laid out its plans for the years ahead, and the expectations aren't entirely unreasonable.\nIf you've been thinking about adding this dividend-paying stock to your portfolio, now looks like a great time to act for a lot of good reasons. Here are three of the most important ones.\n1. Dividend raises ahead\nCVS Health is generally a reliable dividend raiser, but the company froze its payout in place in 2017 to help with the $69 billion acquisition of Aetna in 2018. CVS Health took on a lot of debt to become a healthcare benefits manager and wisely decided to freeze dividend payments in place until its financial leverage ratio reached a more comfortable level.\n\nCVS Dividend data by YCharts\nThe company's a bit more levered up than it was just ahead of the Aetna acquisition. At a financial leverage ratio below 0.8, though, it's more than likely safe to show shareholders a lot more appreciation.\nEffective Feb. 1, 2022, patient CVS Health shareholders will receive a $0.55 dividend payment or 10% more than they've been receiving since late 2017. Also, the company intends to return $10 billion to investors in the form of share buybacks.\nAt recent prices, the impending buybacks could reduce CVS Health's outstanding share count by more than 7% at recent prices. This will make it even easier to bump the payout higher in the years ahead.\n2. Chance to outdo UnitedHealth\nThanks to the Affordable Care Act, private healthcare plan sponsors, Medicare, and Medicaid increasingly pay fixed rates for specific conditions. This means running patients through more tests and services than they need leads to losses on the bottom line for companies like CVS Health. It also means that coordinating primary care in a way that keeps patients healthy and out of the hospital can lead to windfall profits.\nUnitedHealth Group (NYSE:UNH) doesn't bring in quite as much revenue as CVS Health, but it's been generating around twice as much net income. A large part of UnitedHealth's rise to the top can be attributed to an internal network of doctors. UnitedHealth employs or at least has a relationship with 60,000 U.S. physicians. Taking money from healthcare plan sponsors and using it to pay providers is a lot easier to manage when you employ the providers.\n\nCVS Revenue (TTM) data by YCharts\nCVS Health employs more pharmacists than UnitedHealth, but drugs are a relatively minor expense. In 2019, National Health Expenditure data found that prescription drugs made up just 10% of America's $3.8 trillion healthcare bill that year. Physician and clinical services worked out to 21% and hospitals soaked up the largest share at 30% of total healthcare spending.\nWith more than 9,000 physical locations spread throughout the U.S., CVS Health has a chance to employ more of the cost-saving measures that UnitedHealth Group enjoys. At the moment, CVS Health manages 1,200 walk-in medical clinics that employ around 4,000 nurse practitioners and physician assistants. It won't happen overnight, but better coordination of primary care could make CVS Health's profit margins resemble United Health's.\n3. Ability to keep raising the payout\nAt recent prices, CVS Health stock offers a 2.2% yield and a pretty good chance to see that payout rise into the clouds. Over the past year, CVS Health generated a whopping $15.2 billion in free cash flow and used just $2.7 billion to make payments.\nWith its debt load under control, the company can raise its dividend payout in line with earnings growth. Vaccine distribution revenue might slacken in the years ahead but growth ahead seems like a reasonable prediction. A steadily aging U.S. population is going to need more healthcare year after year for decades to come.","news_type":1},"isVote":1,"tweetType":1,"viewCount":794,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":4,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}